First-line Treatment Failure Nasopharyngeal Carcinoma
1 clinical trials · Condition
◉ Watch First-line Treatment Failure Nasopharyngeal Carcinoma
| Record | Firm | Date |
|---|---|---|
| Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatment Failure: A Single-arm Phase IIa Clinical Trial (NCT07101744) | Sun Yat-sen University | 2025-10-17 |
Track First-line Treatment Failure Nasopharyngeal Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.